Evidence map›Paper›PMID 41745487›Full record

ArticleMarine drugs2026

Synthesis, Biological Evaluation, and Computational Studies of Phenolic

Wenjie Wang, Kun Gao, Guantian Li, Zongji Wang, Kecheng Li, Song Liu, Huahua Yu, Ronge Xing

Abstract read
In one paragraph

Article in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wenjie WangLaboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266000, China.
Kun GaoLaboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266000, China.
Guantian LiLaboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266000, China.
Zongji WangRegenerative Medicine Innovation Institute, Linyi University, Linyi 276012, China.
Kecheng LiLaboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266000, China.ORCID 0000-0001-8862-9943
Song LiuLaboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266000, China.
Huahua YuLaboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266000, China.ORCID 0000-0003-3213-6212
Ronge XingLaboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266000, China.

Funding

Modern Agro-industry Technology Research System CARS-49Qingdao Natural Science Foundation 25-1-1-186-zyyd-jchThe Key R&D Program (Major Scientific and Technological Innovation Project) of Shandong Province, China 2022CXGC020413the National Natural Science Foundation of China 42276097, 42406119
6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is one of the most prevalent chronic metabolic diseases, and inhibition of α-glucosidase activity represents an effective therapeutic strategy. Chitin is the most abundant renewable polysaccharide in the ocean, with its monosaccharide being

Indexed as

DFTdiabetesmolecular dynamicN-acetylglucosamine glycosidephenolsα-glucosidase inhibitor

Identifiers

PMID41745487
PMCPMC12942185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.